MERLINI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 458
EU - Europa 295
AS - Asia 145
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 904
Nazione #
US - Stati Uniti d'America 457
IT - Italia 189
SG - Singapore 81
IE - Irlanda 38
SE - Svezia 24
CN - Cina 19
ID - Indonesia 19
FI - Finlandia 17
FR - Francia 11
JP - Giappone 9
HK - Hong Kong 6
VN - Vietnam 5
DE - Germania 3
NL - Olanda 3
UA - Ucraina 3
AU - Australia 2
ES - Italia 2
GB - Regno Unito 2
KR - Corea 2
NO - Norvegia 2
OM - Oman 2
TW - Taiwan 2
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
EU - Europa 1
MA - Marocco 1
TG - Togo 1
Totale 904
Città #
Chandler 91
Singapore 61
Turin 58
Ann Arbor 51
Dublin 38
Fairfield 28
Milan 23
Jakarta 19
Ashburn 18
Nyköping 14
Wilmington 12
Helsinki 10
Torino 10
Woodbridge 9
Genoa 8
Rome 8
Lappeenranta 7
Medford 7
Princeton 7
Seattle 7
Cambridge 6
Carrara 6
Houston 6
Santa Clara 5
Beijing 4
Cagliari 4
New York 4
Tokyo 4
Bologna 3
Boston 3
Cuneo 3
Hebei 3
Nuvolera 3
Paris 3
Pocapaglia 3
Upper Marlboro 3
Assago 2
Collegno 2
Formello 2
Grugliasco 2
Guiyang 2
Hangzhou 2
Hong Kong 2
Jacksonville 2
Kawasaki 2
Messina 2
Muscat 2
Nules 2
Reggio Calabria 2
Reno 2
San Diego 2
Seoul 2
Settimo Torinese 2
Stavanger 2
Taichung 2
Tampa 2
Toulouse 2
Washington 2
Alessandria 1
Amsterdam 1
Atlanta 1
Augusta 1
Aurora 1
Brescia 1
Chengdu 1
Chicago 1
Concesio 1
Coreglia Antelminelli 1
Dong Ket 1
Eitensheim 1
Englewood 1
Fremont 1
Fuzhou 1
Lastra A Signa 1
Leiden 1
Lomé 1
Moncalieri 1
Mountain View 1
New Haven 1
Nichelino 1
Nijmegen 1
Ottawa 1
Padova 1
Pasadena 1
Putian 1
Recife 1
Redwood City 1
Riverton 1
Salé 1
San Jose 1
Sapporo 1
Shanghai 1
Shenzhen 1
Tamworth 1
Tappahannock 1
Zurich 1
Totale 631
Nome #
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights 136
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 103
Response to Eribulin in a patient with metastatic uterine leiomyosarcoma: a case report 92
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 87
Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors 60
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 58
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 53
Delving into PARP inhibition from bench to bedside and back 45
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 35
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19 25
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 22
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study 19
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial 19
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study 18
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions 18
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade 18
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes 17
The role of germline mutations in thoracic malignancies: between myth and reality 17
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST) 16
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group 13
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group 12
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets 12
Being the ultimate travel companion of a patient with uterine leiomyosarcoma 11
A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis 11
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer 10
Experience with second-line trabectedin in daily clinical practice: case studies 9
Age- and pregnancy-associated DNA methylation changes in mammary epithelial cells 6
GDF-15 predicts epithelioid hemangioendothelioma aggressiveness and is down-regulated by sirolimus through ATF4/ATF5 suppression 6
Totale 948
Categoria #
all - tutte 5.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 3 4 7 3 1 3
2020/202183 6 3 8 7 4 9 2 5 4 14 2 19
2021/2022170 25 5 7 10 7 8 16 14 6 10 43 19
2022/2023275 16 15 6 26 25 66 36 18 37 3 15 12
2023/2024277 26 58 16 27 18 29 15 15 5 11 24 33
2024/2025122 7 61 54 0 0 0 0 0 0 0 0 0
Totale 948